|
" The new dimensions of warfarin prophylaxis "
edited by Stanford Wessler, Carl G. Becker, and Yale Nemerson.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
730956
|
| Doc. No
|
:
|
b550739
|
| Main Entry
|
:
|
edited by Stanford Wessler, Carl G. Becker, and Yale Nemerson.
|
| Title & Author
|
:
|
The new dimensions of warfarin prophylaxis\ edited by Stanford Wessler, Carl G. Becker, and Yale Nemerson.
|
| Publication Statement
|
:
|
New York: Plenum Press, ©1987.
|
| Series Statement
|
:
|
Advances in experimental medicine and biology, v. 214.
|
| Page. NO
|
:
|
(ix, 329 pages) : illustrations
|
| ISBN
|
:
|
1475759851
|
|
|
:
|
: 9781475759853
|
| Contents
|
:
|
The Scope of Thromboembolism.- Vitamin K-Dependent Proteins.- The Biochemical Basis of Warfarin Therapy.- Warfarin and the Biochemistry of the Vitamin K Dependent Proteins.- Anticoagulation Proteins C and S.- Warfarin and Bone: Implications for Rational Strategies to Selectively Antagonize the Action of Vitamin K in Target Tissues.- Human Genes for Factor IX and Other Vitamin K Dependent Blood Proteins.- The Prothrombin Time.- Tissue Factor.- INR - Calibration of the Therapeutic Range.- Cold-Promoted Activation of Factor VII and Shortening of the Prothrombin Time.- Immunologic Aspects of Vessel Injury and Thrombosis.- What's The Dose?.- Venous Thromboembolism - Primary Prophylaxis.- Venous Thromboembolism in Moderate Risk Patients.- Two-Step Warfarin Therapy for the Prophylaxis of Venous Thrombosis after Elective Surgery.- Prevention of Venous Thromboembolism in High-Risk Patients by Prophylactic Administration of Oral Anticoagulants.- Genetic Coagulation Defects.- Venous Thromboembolism - Secondary Prophylaxis.- Treatment of First Episode of Venous Thrombosis.- Management of Recurrent Venous Thromboembolism.- Special Issues.- Warfarin Metabolism and Drug-Drug Interactions.- Improving the Benefit/Risk Ratio.- Oral Anticoagulant Therapy and Skin Necrosis: Speculations on Pathogenesis.- Cardiovascular - Arterial Thromboembolism.- Clinical Trials in Myocardial Infarction and Coronary Heart Disease.- Anticoagulants in Acute Myocardial Infarction.- Long-Term Anticoagulant Treatment after Acute Myocardial Infarction.- Following Coronary Thrombolysis.- Arterial Thromboembolism: Valvular Heart Disease and Prosthetic Heart Valves.- Neurovascular - Arterial Thromboembolism.- Clinical Trial Dilemmas and Cerebrovascular Disease.- Atrial Fibrillation and Stroke: The View from Cardiology.- Atrial Fibrillation and Stroke: The View from Neurology.- Cardiac Embolic Stroke: Anticoagulating the Elderly.- Anticoagulants for the Treatment of Transient Ischemic Attacks.- Epilogue.- Contributors.
|
| Subject
|
:
|
Thrombolytic therapy -- Congresses.
|
| Subject
|
:
|
Thrombosis -- Prevention -- Congresses.
|
| Subject
|
:
|
Warfarin -- Congresses.
|
| LC Classification
|
:
|
RC694.3E358 1987
|
| Added Entry
|
:
|
Carl G Becker
|
|
|
:
|
Stanford Wessler
|
|
|
:
|
Yale Nemerson
|
| |